NervGen Pharma Corp. to Present at the 9th Annual LD Micro Invitational
LOS ANGELES, CA / ACCESSWIRE / June 4, 2019 / NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a regenerative medicine...
LOS ANGELES, CA / ACCESSWIRE / June 4, 2019 / NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a regenerative medicine...
Annual Awards Program Recognizes Outstanding Digital Health & Medical Technology Products and CompaniesASHTEAD, UK – June 4, 2019 – BridgeHead...
LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares...
Initial Purchase by Beijing Dahua Sanxin Technology Development Co., Ltd. Represents First MiOXSYS Commercial Sale in China. ENGLEWOOD, CO /...
SAN CLEMENTE, CA / ACCESSWIRE / June 4, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Expands Market Presence in Asia Pacific Region REDWOOD CITY, CA / ACCESSWIRE / June 4, 2019 / Avinger, Inc. (NASDAQ:...
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 is 50- to 300-fold more potent than approved PDE4 inhibitors Phase...
A double board-certified Anesthesiologist, Dr. Nikesh Seth is also CEO of Integrated Pain Consultants with three locations in Arizona; Consistently...
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit WEST PALM BEACH, FL / ACCESSWIRE / June 3,...
ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of...
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain - NanoVibronix...
20-Year Global Commercial Medical Imaging Veteran to Lead Rollout of ENDRA Technology in European and U.S. Markets ANN ARBOR, MI...
MALVERN, PA / ACCESSWIRE / June 3, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products...
SAN FRANCISCO, CA / ACCESSWIRE / June 3, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
Clinical benefit observed in 55% of patients receiving HS-110 plus nivolumab after checkpoint inhibitor treatment failureHS-110 in combination with nivolumab...
WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today...
ALACHUA, FL / ACCESSWIRE / May 31, 2019 / CTD Holdings, Inc. (OTCQB: CTDH)("CTD" or the "Company"), a clinical stage...
TAMPA, FL / ACCESSWIRE / May 31, 2019 / Advanzeon Solutions, Inc. (OTC PINK: CHCR) ("Advanzeon" or the "Company") announced...
ANAHEIM, CA / ACCESSWIRE / May 31, 2019 / BioCorRx Inc. (OTCQB: BICX) (the "Company"), a leader, developer and provider...
The medical sector is one that has truly reaped the rewards of technological advancement in recent years, from 3D printing...